Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter study.
MetadataShow full item record
<h4>Background</h4>An increasing number and proportion of cancer patients with apparently localised disease are treated with chemotherapy and radiation therapy in contemporary oncology practice. In a pilot study of radiation-induced sarcoma (RIS) patients, we demonstrated that chemotherapy was associated with a reduced time to development of RIS. We now present a multi-centre collaborative study to validate this association.<h4>Methods</h4>This was a retrospective cohort study of RIS cases across five large international sarcoma centres between 1 January 2000 to 31 December 2014. The primary endpoint was time to development of RIS.<h4>Results</h4>We identified 419 patients with RIS. Chemotherapy for the first malignancy was associated with a shorter time to RIS development (HR 1.37; 95% CI: 1.08-1.72; P=0.009). In the multi-variable model, older age (HR 2.11; 95% CI 1.83-2.43; P<0.001) and chemotherapy for the first malignancy (HR 1.61; 95% CI 1.26-2.05; P<0·001) were independently associated with a shorter time to RIS. Anthracyclines and alkylating agents significantly contribute to the effect.<h4>Conclusions</h4>This study confirms an association between chemotherapy given for the first malignancy and a shorter time to development of RIS.
Version of record
Neoplasms, Second Primary
Antineoplastic Agents, Alkylating
Aged, 80 and over
Sarcoma Clinical Trials
License start date
British journal of cancer, 2017, 117 (3), pp. 326 - 331